Table 5.
T0–T1 Between-Group Difference |
T0–T2 Between-Group Difference |
T0–T3 Between-Group Difference |
T0–T4 Between-Group Difference |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean Change (SE) | p | ES | Mean Change (SE) | p | ES | Mean Change (SE) | p | ES | Mean Change (SE) | p | ES | |
Cognitive Functioning | 1.91 (2.78) | 0.492 | 0.12 | −0.61 (3.90) | 0.876 | −0.04 | 0.86 (4.36) | 0.845 | 0.05 | −3.98 (4.50) | 0.379 | −0.25 |
Physical Functioning | −5.63 (2.49) | 0.025 | −0.49 | 2.56 (3.32) | 0.441 | 0.21 | 1.83 (3.57) | 0.609 | 0.15 | −2.08 (2.95) | 0.482 | −0.17 |
Nausea/Vomiting | 6.34 (3.63) | 0.083 | 0.38 | 2.45 (3.78) | 0.518 | 0.15 | 1.66 (4.10) | 0.686 | 0.10 | 0.18 (3.44) | 0.959 | 0.01 |
Diarrhea | 0.77 (4.48) | 0.864 | 0.05 | −17.68 (5.06) | 0.001 | −1.15 | −13.98 (5.56) | 0.013 | −0.91 | −12.30 (5.12) | 0.018 | −0.80 |
Corrected * | −1.13 (3.49) | 0.365 | −0.10 | −18.84 (3.50) | <0.001 | −1.60 | −15.34 (3.66) | 0.018 | −1.30 | −13.56 (3.95) | 0.001 | −1.15 |
QLQ C30 summary score | −2.36 (2.18) | 0.280 | −0.20 | 3.44 (2.95) | 0.246 | 0.29 | 1.86 (3.02) | 0.538 | 0.16 | −1.50 (3.10) | 0.629 | −0.13 |
* corrected for tumor localization.